Dr Reddy's launches generic epilepsy drug in US
New Delhi: Dr Reddy's Laboratories said it has launched Levetiracetram in Sodium Chloride injection, an anti-epileptic drug, in the US market.
The Hyderabad-based company's drug is the generic version of HQ Specialty Pharma Corporation's product, Dr Reddy's Laboratories said in a statement.
According to IMS Health data, Levetiracetam in Sodium Chloride injection brand and generics had sales of around USD 37 million in the US market.
anti-epileptic drugDr ReddyDr Reddy'sDr Reddy's LaboratoriesDr Reddy's Labsepilepsy druggenericgeneric versionlaunchesLevetiracetam in Sodium Chloride injectionLevetiracetramSodium Chloride injectionUSUS market
Source : PTINext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd